IP Library › Granted Patent US 12,721,574
Granted Patent B2
US 12,721,574 · App. 17/776,752 · Granted Sep 1, 2026

Pressure measurement

Inventor: Martin F. Burns (Los Angeles, CA)
Assignee: BRUIN BIOMETRICS, LLC
A61B5/7275A61B5/1036A61B5/447A61B5/6892G16H50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,721,574
App. No.
17/776,752
Granted
Sep 1, 2026
Kind
B2
Abstract

The present disclosure provides methods and apparatus for evaluating tissue structure in damaged or healing tissue. The present disclosure also provides methods of identifying a patient at the onset of risk of pressure ulcer or at risk of the onset of pressure ulcer, and treating the patient with anatomy-specific clinical interventions selected, based on pressure measurements. The present disclosure also provides methods of stratifying groups of patients based on risk of wound development and methods of reducing incidence of tissue damage in a care facility. The present disclosure also provides methods to analyze trends of pressure values to detect tissue damage before it is visible, and methods to compare bisymmetric pressure values to identify damaged tissue.

Claims (50)

1 . A method for identifying and providing an appropriate level of care to a patient in a care facility, the method comprising the steps of:

a) taking a plurality of pressure measurements of the patient at one or more body locations;

b) determining an average pressure value of the plurality of pressure measurements of the patient;

c) providing one or more anatomy-specific interventions based on the average pressure value;

d) increasing the level of anatomy-specific interventions based on an increase in the average pressure value; and

e) decreasing the level of anatomy-specific interventions based on a decrease in the average pressure value.

2 . A method of managing care of a patient, the method comprising the steps of:

a) taking a first set of pressure measurements at one or more body locations selected for monitoring upon admission to a care facility;

b) determining a first average pressure value of each of the first set of pressure measurements;

c) setting an intervention level to N=1 if one of the average pressure value of the first set of pressure measurements is above a first threshold;

d) implementing a level-N intervention for each of the one or more body locations having an average pressure value above a first threshold;

e) taking subsequent sets of pressure measurements at each of the one or more body locations at a level-N frequency; and

f) determining new average pressure values for each of the one or more body locations.

3 . The method of claim 2 , wherein the one or more body locations selected for monitoring are selected from the group consisting of a sternum, a sacrum, a heel, a scapula (os latum scapularum), an elbow, an ear, and other fleshy tissues over a bony prominence of a patient.

4 . The method of claim 2 , wherein one or more body locations selected for monitoring comprise one or more anatomical sites in long-term contact with a medical device, and are selected from the group consisting of a cheek, a nose, a chest, a stomach, and a lower abdomen area.

5 . A method of identifying and treating a patient at risk of tissue damage, the method comprising the steps of:

a) evaluating a patient for a risk of tissue damage upon admission to a care facility, wherein the evaluating step comprises:

i) taking a first plurality of pressure measurements in the patient;

ii) determining a first average pressure value of the first plurality of pressure measurements;

b) administering a first intervention of level-0 if the first average pressure value is below or equal to a first threshold; and

c) administering a first intervention of level-N if the first average pressure value is above the first threshold, where N is an integer and N has a value of 1 or greater.

6 . The method of claim 5 , further comprising the steps of:

a) taking a second plurality of pressure measurements in the patient at a first pre-determined frequency corresponding to the administered intervention level;

b) determining a second average pressure value of the second plurality of pressure measurements;

c) determining whether the second average pressure value exceeds a second threshold;

d) continuing to administer the first intervention if the second average pressure value does not exceed the second threshold;

e) continuing to take a plurality of pressure measurements at the first pre-determined frequency if the second average pressure value does not exceed the second threshold;

f) administering a second intervention of level-M if the second average pressure value exceeds the second threshold, where M is an integer and M is greater than N; and

g) taking a plurality of pressure measurements at a second pre-determined frequency corresponding to level-M if the second average pressure value exceeds the second threshold.

7 . The method of claim 6 , wherein the second intervention of level-M is selected from the group consisting of a heel boot, a barrier cream, neuromuscular stimulation, a topical cream, therapeutic ultrasound, shockwave therapy, a 30-degree wedge, a composite dressing, a hybrid mattress, a dynamic mattress, a support surface, a silicone pad, a low-friction sheet cover, and a low-friction padded mattress surface.

8 . The method of claim 6 , wherein the second average pressure value is determined from a subset of the second plurality of pressure measurements.

9 . The method of claim 6 , wherein the second threshold is equal to the first threshold.

10 . The method of claim 6 , further comprising the steps of:

a) determining whether the second average pressure value is less than a third threshold;

b) continuing to administer the first intervention if the second average pressure value is not less than the third threshold;

c) continuing to take a plurality of pressure measurements at the first pre-determined frequency if the second average pressure value is not less than the third threshold;

d) administering a third intervention of level-L if the second average pressure value is less than the third threshold and if the first intervention is not of level-0, where L is an integer and L is less than N; and

e) taking a plurality of pressure measurements at a pre-determined frequency corresponding to level-L if the second average pressure value is less than the third threshold.

11 . The method of claim 10 , wherein the third intervention of level-L is selected from the group consisting of a heel boot, a barrier cream, neuromuscular stimulation, a topical cream, therapeutic ultrasound, shockwave therapy, a 30-degree wedge, a composite dressing, a hybrid mattress, a dynamic mattress, a support surface, a silicone pad, a low-friction sheet cover, and a low-friction padded mattress surface.

12 . The method of claim 10 , wherein the third threshold is equal to the first threshold.

13 . The method of claim 5 , wherein the first intervention of level-Nis selected from the group consisting of a heel boot, a barrier cream, neuromuscular stimulation, a topical cream, therapeutic ultrasound, shockwave therapy, a 30-degree wedge, a composite dressing, a hybrid mattress, a dynamic mattress, a support surface, a silicone pad, a low-friction sheet cover, and a low-friction padded mattress surface.

14 . The method of claim 5 , wherein the first average pressure value is determined from a subset of the first plurality of pressure measurements.

15 . A method of identifying and treating a patient in need of an intervention for pressure ulcer, the method comprising the steps of:

a) taking a plurality of pressure measurements at an anatomic site of the patient;

b) determining an average pressure value of the plurality of pressure measurements;

c) determining whether the average pressure value exceeds a threshold corresponding to level N, where N is greater than or equal to 2;

d) administering the intervention for pressure ulcer to the anatomic site if the average pressure value exceeds the threshold; and

e) taking a plurality of pressure measurements every two hours if the average pressure value exceeds the threshold.

16 . The method of claim 15 , wherein the anatomical site is selected from the group consisting of a sternum, a sacrum, a heel, a scapula (os latum scapularum), an elbow, an ear, and other fleshy tissues over a bony prominence of a patient.

17 . The method of claim 15 , wherein the intervention for pressure ulcer is selected from the group consisting of a heel boot, a barrier cream, neuromuscular stimulation, a topical cream, therapeutic ultrasound, shockwave therapy, a 30-degree wedge, a composite dressing, a hybrid mattress, a dynamic mattress, a support surface, a silicone pad, a low-friction sheet cover, and a low-friction padded mattress surface.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2022
From: BURNS, MARTIN F.
To: BRUIN BIOMETRICS, LLC
Reel/Frame 060331/0808 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2022
From: BURNS, MARTIN F.
To: BRUIN BIOMETRICS, LLC
Reel/Frame 060331/0798 →
Continuity (3)
Provisional Application 63109026 · Nov 3, 2020
Provisional Application 62936381 · Nov 15, 2019
Related Publication 20220395235A1 · Dec 15, 2022
References Cited (110)
US 5010772A · Bourland et al. · 1991 [cited by applicant]
US 6013031A · Mendlein et al. · 2000 [cited by applicant]
US 6287253B1 · Ortega et al. · 2001 [cited by applicant]
US 8971984B2 · Freeman · 2015 [cited by examiner]
US 9320665B2 · Main et al. · 2016 [cited by applicant]
US 10020075B2 · Perlman et al. · 2018 [cited by applicant]
US 10028676B2 · Freeman · 2018 [cited by examiner]
US 11395622B2 · Linders · 2022 [cited by examiner]
US 12133763B2 · Burns · 2024 [cited by applicant]
US 12502076B2 · Tran · 2025 [cited by examiner]
US 20030220581A1 · Ollmar et al. · 2003 [cited by applicant]
US 20050165284A1 · Gefen · 2005 [cited by examiner]
US 20060065060A1 · Ito et al. · 2006 [cited by applicant]
US 20070197904A1 · Viglianti et al. · 2007 [cited by applicant]
US 20080103207A1 · Dayan · 2008 [cited by applicant]
US 20080132808A1 · Lokhorst et al. · 2008 [cited by applicant]
US 20080194928A1 · Bandic et al. · 2008 [cited by applicant]
US 20080279438A1 · West et al. · 2008 [cited by applicant]
US 20090068685A1 · Streeper et al. · 2009 [cited by applicant]
US 20090070939A1 · Hann et al. · 2009 [cited by applicant]
US 20100158332A1 · Rico et al. · 2010 [cited by applicant]
US 20100172567A1 · Prokoski · 2010 [cited by applicant]
US 20100268111A1 · Drinan · 2010 [cited by examiner]
US 20100324455A1 · Rangel · 2010 [cited by examiner]
US 20110215930A1 · Lee et al. · 2011 [cited by applicant]
US 20110301441A1 · Bandic et al. · 2011 [cited by applicant]
US 20120232403A1 · Smith · 2012 [cited by applicant]
US 20130006151A1 · Main et al. · 2013 [cited by applicant]
US 20140092288A1 · Hattery et al. · 2014 [cited by applicant]
US 20150164467A1 · Suetoshi et al. · 2015 [cited by applicant]
US 20160113667A1 · Bailey et al. · 2016 [cited by applicant]
US 20160135731A1 · Drennan · 2016 [cited by applicant]
US 20160253800A1 · Gurevich et al. · 2016 [cited by applicant]
US 20170196489A1 · Horras et al. · 2017 [cited by applicant]
US 20170224271A1 · Lachenbruch et al. · 2017 [cited by applicant]
US 20170236281A1 · Dacosta · 2017 [cited by applicant]
US 20170311807A1 · Fu et al. · 2017 [cited by applicant]
US 20170325683A1 · Larson et al. · 2017 [cited by applicant]
US 20170347891A1 · Rogers et al. · 2017 [cited by applicant]
US 20180042483A1 · Bardhan et al. · 2018 [cited by applicant]
US 20180098727A1 · Spahn et al. · 2018 [cited by applicant]
US 20180360344A1 · Burns et al. · 2018 [cited by applicant]
US 20190021650A1 · Lee et al. · 2019 [cited by applicant]
US 20190100802A1 · Sanada et al. · 2019 [cited by applicant]
US 20190104982A1 · Dunn et al. · 2019 [cited by applicant]
US 20190125248A1 · Curtin · 2019 [cited by applicant]
US 20190142333A1 · Burns et al. · 2019 [cited by applicant]
US 20190160116A1 · Muller et al. · 2019 [cited by applicant]
US 20190175098A1 · Burns et al. · 2019 [cited by applicant]
US 20190246972A1 · Burns et al. · 2019 [cited by applicant]
US 20190307904A1 · Ballamy · 2019 [cited by applicant]
US 20200009123A1 · Hakozaki et al. · 2020 [cited by applicant]
US 20200104997A1 · Takagi · 2020 [cited by applicant]
US 20220386941A1 · Burns · 2022 [cited by applicant]
US 20220400956A1 · Burns · 2022 [cited by applicant]
US 20220401015A1 · Burns · 2022 [cited by applicant]
US 20220401063A1 · Burns · 2022 [cited by applicant]
US 20250017555A1 · Burns · 2025 [cited by applicant]
CA 2620288A1 · 2009 [cited by applicant]
CN 104219994A · 2014 [cited by applicant]
JP 2004105446A · 2004 [cited by applicant]
JP 2013510620A · 2013 [cited by applicant]
JP 2016224396A · 2016 [cited by applicant]
JP 2017012427A · 2017 [cited by applicant]
JP 2018089368A · 2018 [cited by applicant]
JP 2018093901A · 2018 [cited by applicant]
WO 2011058457A1 · 2011 [cited by applicant]
WO 2013114356A1 · 2013 [cited by applicant]
WO 2013151705A9 · 2013 [cited by applicant]
WO WO2017048979A1 · 2017 [cited by examiner]
WO 2019099810A1 · 2019 [cited by applicant]
WO 2019178583A1 · 2019 [cited by applicant]
WO 2021096992A1 · 2021 [cited by applicant]
WO 2021096994A9 · 2021 [cited by applicant]
WO 2021097033A1 · 2021 [cited by applicant]
WO 2021097037A2 · 2021 [cited by applicant]
WO 2021097079A1 · 2021 [cited by applicant]
WO 2021097081A1 · 2021 [cited by applicant]
WO 2021097083A1 · 2021 [cited by applicant]
WO WO2021096994A1 · 2021 [cited by examiner]
WO 2021096993A1 · 2021 [cited by applicant]
Bates-Jensen et al., “Subepidermal Moisture Detection of Pressure Induced Tissue Damage on the Trunk: The Pressure Ulcer Detection (PUD) Study Outcomes”, May 2017, Wound Repair Regen. 25(3): 502-511. doi:10.1111/wrr.125… [cited by examiner]
Gehen, “The future of pressure ulcer prevention is here: Detecting and targeting inflammation early”, 2018, EWMA Journal, vol. 19 No. 2, pp. 7-13 (Year: 2018). [cited by examiner]
Kanno et al., “Low-Echoic Lesions Underneath the Skin in Subjects with Spinal-Cord Injury,” [cited by applicant]
Scheiner et al., “Ultrasound to Detect Pressure-Related Deep Tissue Injuries in Adults Admitted via the Emergency Department: A Prospective, Descriptive, Pilot Study,” [cited by applicant]
Supplementary European Search Report for European Application 20886304, completed May 30, 2023. [cited by applicant]
Supplementary European Search Report for European Application 20888629, completed May 30, 2023. [cited by applicant]
Supplementary European Search Report for European Application 20887519, completed Oct. 11, 2023. [cited by applicant]
Yabunaka et al., “Three-Dimensional Ultrasound Imaging of the Pressure Ulcer. A Case Report,” [cited by applicant]
Aoi et al., “Ultrasound Assessment of Deep Tissue Injury in Pressure Ulcers: Possible Prediction of Pressure Ulcer Progression,” [cited by applicant]
Bergstrom et al., “The Braden Scale for Predicting Pressure Sore Risk,” [cited by applicant]
Brem et al., “High Cost of Stage IV Pressure Ulcers,” [cited by applicant]
Garcia-Fernandez, “Predictive Capacity of Risk Assessment Scales and Clinical Judgment for Pressure Ulcers: A Meta-Analysis,” [cited by applicant]
Huong et al., “Multispectral Imaging of Acute Wound Tissue Oxygenation,” [cited by applicant]
International Search Report for PCT/US2020/060067 dated Mar. 17, 2021. [cited by applicant]
International Search Report for PCT/US2020/060211 dated Mar. 17, 2021. [cited by applicant]
International Search Report for PCT/US2020/060062 dated Mar. 18, 2021. [cited by applicant]
International Search Report for PCT/US2020/060063 dated Mar. 18, 2021. [cited by applicant]
International Search Report for PCT/US2020/060219 dated Mar. 18, 2021. [cited by applicant]
International Search Report for PCT/US2020/060064 dated Mar. 25, 2021. [cited by applicant]
International Search Report for PCT/US2020/060145 dated Mar. 25, 2021. [cited by applicant]
International Search Report for PCT/US2020/060222 dated Mar. 25, 2021. [cited by applicant]
International Search Report for PCT/US2020/060151 dated May 7, 2021. [cited by applicant]
The National Institute for Health and Care Excellence (NICE), “Pressure Ulcers: Prevention and Management,” Clinical Guideline, 29 pp. (Apr. 23, 2014), National Institute for Health and Care Excellence (publisher), Lond… [cited by applicant]
Nelissen et al., “An Advanced Magnetic Resonance Imaging Perspective on the Etiology of Deep Tissue Injury,” [cited by applicant]
Pancorbo-Hidalgo et al., “Risk Assessment Scales for Pressure Ulcer Prevention: A Systematic Review,” [cited by applicant]
Ruan et al., “Magnetic Resonance Imaging of Nonhealing Pressure Ulcers and Myocutaneous Flaps,” [cited by applicant]
Yafi et al., “Quantitative Skin Assessment Using Spatial Frequency Domain Imaging (SFDI) in Patients with or at High Risk for Pressure Ulcers,” [cited by applicant]
Yudovsky et al., “Assessing Diabetic Foot Ulcer Development Risk with Hyperspectral Tissue Oximetry,” [cited by applicant]
Anonymous, “Wound Home Skills Kit: Pressure Ulcers,” American College of Surgeons, Division of Education, Surgical Patient Education Program: Prepare for the Best Recovery, https://www.facs.org/media/32hdibi4/wound_pres… [cited by applicant]